Topic: Medical Studies

Joe Atwell details the Harvard Pilgrim Study, which allegedly found that the VAERS system only captures 1% of vaccine side effects. He proposes that RFK Jr. should use AI and modern computing to correlate hundreds of millions of hospital records dating back to the 1940s. This large-scale data analysis would aim to provide definitive answers on the links between vaccines and conditions like autism.

Greg Carlwood reviews the data from 203 historical contagion experiments cited in Daniel Roydas's book. He notes that in studies where healthy people were exposed to sick donors through coughing, sneezing, and shared items, only 12% became ill. Furthermore, 10% of control groups developed symptoms after receiving an inert placebo, suggesting that the nocebo effect and psychological expectation play a significant role in respiratory illness.

Dr. Popper compares medical decisions to purchasing a home or a car, arguing that people often abandon their critical thinking skills when dealing with doctors. She uses the analogy of a million-dollar lease agreement to emphasize that patients should read medical documents and ask questions rather than deferring to authority. Popper maintains that anyone can be taught to read medical studies to avoid harmful diets, supplements, or unnecessary surgeries.

To meet the gold standard of medical research, Sententia has developed a double-blind protocol for energy healing. In this setup, the practitioner does not know if they are performing a real or placebo treatment until they are in a separate room from the patient. This removes the influence of practitioner confidence and unconscious cues, addressing the primary criticism of existing single-blind studies in the field.

Rick Simpson recounts how the death of his cousin in 1972 and a 1975 radio report about a Virginia Medical School study shaped his path. The study proved that THC kills cancer cells, yet the U.S. government kept the plant as a Schedule I substance. Simpson points out the hypocrisy of the government filing medicinal patents on cannabis in 2003 while simultaneously claiming it has no medical value.